(BTHM) BlackRock Trust - - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US09290C8064 • Large Blend
BTHM: Equity, Securities, Stocks
The BlackRock Future U.S. Themes ETF (BTHM) is designed to capitalize on emerging U.S. equity opportunities with elevated growth potential. Under normal market conditions, the fund allocates at least 80% of its net assets plus borrowings to U.S. equity securities, focusing on companies with above-average earnings growth prospects. Its investment universe includes common stocks, preferred stocks, convertible securities, warrants, and depositary receipts linked to common stock values. As a non-diversified fund, it may concentrate its holdings in fewer issuers, which can amplify both potential returns and risks. The fund is structured to provide exposure to a mix of large-cap and mid-cap companies, aligning with the Large Blend ETF category.
Based on the provided data, here is a 3-month forecast for BTHM:
Ticker Symbol: BTHM | Exchange: NYSE ARCA | Type: ETF | Country Origin: USA | ETF Category: Large Blend
Technical Outlook: The funds price of 32.84 is currently below its 20-day (34.43) and 50-day (34.32) moving averages, indicating near-term weakness. However, it remains above the 200-day moving average (32.50), suggesting longer-term support. The average true range (ATR) of 0.42 reflects moderate volatility, with a 20-day average volume of 641,497 shares. Over the next three months, BTHM may face resistance near its 50-day moving average (34.32) and find support around its 200-day moving average (32.50). Expect price fluctuations within a narrow range due to the low ATR.
Fundamental Outlook: With assets under management (AUM) of $377.52 million, BTHM maintains a stable size, allowing for efficient trading without significant market impact. The funds focus on growth-oriented U.S. equities positions it to benefit from sectors experiencing above-average earnings expansion. However, its non-diversified nature and concentration in select securities may lead to heightened volatility during market downturns. Over the next three months, BTHMs performance will likely align with broader market trends, with potential outperformance in sectors with strong earnings growth.
Additional Sources for BTHM ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BTHM ETF Overview
Market Cap in USD | 510m |
Category | Large Blend |
TER | 0.60% |
IPO / Inception | 2021-12-14 |
BTHM ETF Ratings
Growth 5y | 51.6% |
Fundamental | - |
Dividend | 35.4% |
Rel. Strength | 0.45 |
Analysts | - |
Fair Price Momentum | 30.36 USD |
Fair Price DCF | - |
BTHM Dividends
Dividend Yield 12m | 0.74% |
Yield on Cost 5y | 0.98% |
Annual Growth 5y | 9.77% |
Payout Consistency | 92.9% |
BTHM Growth Ratios
Growth Correlation 3m | -54.5% |
Growth Correlation 12m | 84.7% |
Growth Correlation 5y | 84.2% |
CAGR 5y | 8.97% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 1.02 |
Alpha | 6.49 |
Beta | 0.000 |
Volatility | 21.16% |
Current Volume | 84.8k |
Average Volume 20d | 236.5k |
As of March 31, 2025, the stock is trading at USD 32.13 with a total of 84,809 shares traded.
Over the past week, the price has changed by -1.32%, over one month by -3.44%, over three months by -4.73% and over the past year by +10.48%.
Partly, yes. Based on ValueRay Analyses, BlackRock Trust - (NYSE ARCA:BTHM) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 51.63 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BTHM as of March 2025 is 30.36. This means that BTHM is currently overvalued and has a potential downside of -5.51%.
BlackRock Trust - has no consensus analysts rating.
According to ValueRays Forecast Model, BTHM BlackRock Trust - will be worth about 32.8 in March 2026. The stock is currently trading at 32.13. This means that the stock has a potential upside of +2.05%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 32.8 | 2.1% |